DSM Announces Biologics Development and Manufacturing Agreement for Australian Facility

Posted on Oct 25, 2012 in News | 0 comments

DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that...

Read More

Pin It on Pinterest